MedPath

Effect of Intracuff Alkalinized Lidocaine on Coughing Incidence at Extubation

Phase 4
Completed
Conditions
Coughing
Lidocaine
Endotracheal Cuff
Extubation
Interventions
Procedure: Endotracheal intubation with injection of liquid in the cuff
Registration Number
NCT01774292
Lead Sponsor
Université de Sherbrooke
Brief Summary

The purpose of the study is to determined whether the administration of alkalized 4% lidocaine (160 mg) in the endotracheal tube cuff is effective in diminishing the incidence of coughing at extubation in surgeries lasting more than 2 hours without the use of nitrous oxide as an anesthetic agent.

Detailed Description

The diffusion of nitrous oxide inside the endotracheal cuff leads to increase pressure, pain and coughing. Studies have shown benefit of alkalized lidocaine and other mediums within the cuff with nitrous oxide. No study has yet evaluated the benefit of alkalized lidocaine in long surgeries without the use of nitrous oxide.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • ASA 1,2 or 3 patients requiring general anesthesia for an elective urological or gynecological surgery predicted to last more than 2 hours
Exclusion Criteria
  • Patient refusal
  • Lidocaine allergy
  • Any allergies to drugs or anesthetics used during the study
  • Under 18 years of age
  • Pregnant
  • Previous airway surgery
  • Cormack 3 or 4 or anticipated difficult airway
  • Upper respiratory tract infection in the last month
  • Active respiratory disease
  • Chronic cough or throat pain
  • Gastro-esophageal reflux disease or at risk for aspiration

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Alkalized lidocaineEndotracheal intubation with injection of liquid in the cuff160 mg of 4% lidocaine (4 ml) in the endotracheal cuff and add bicarbonate 8,4% until appropriate seal.
Sterile salineEndotracheal intubation with injection of liquid in the cuff4 mL of sterile saline in the endotracheal cuff and add bicarbonate 8,4% until appropriate seal.
Primary Outcome Measures
NameTimeMethod
Coughing24 hours after the end ofsurgery
Secondary Outcome Measures
NameTimeMethod
Nausea and Vomiting24 hours after end of surgery
Throat pain24 hours after the end of surgery
Hoarseness of the voice24 hours after end of surgery

Trial Locations

Locations (1)

Centre Hospitalier Universitaire de Sherbrooke

🇨🇦

Sherbrooke, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath